image
Entrada Therapeutics, Inc. TRDA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 17.85
-6.25 %
$ 668 M
Market Cap
12.4
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% 92.36% 96.75%
Annual Report FY 10-K 2022-12-31 0.00% -74.66% -90.21%
Annual Report FY 10-K 2021-12-31 0.00% -89.82% -91.72%
Annual Report FY 10-K 2020-12-31 0.00% -467.41% -125.53%
Annual Report FY 10-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -55.25% -39.57% -154.57%
Quarterly Report Q2 8-K 2024-06-30 421.16% 312.25% 427.77%
Quarterly Report Q1 8-K 2024-03-31 134.05% 452.05% 1497.05%
Quarterly Report Q4 8-K 2023-12-31 0.00% 57.02% 119.18%
Quarterly Report Q3 8-K 2023-09-30 0.00% 250.65% 154.03%
Quarterly Report Q2 8-K 2023-06-30 0.00% -15.89% 30.88%
Quarterly Report Q1 8-K 2023-03-31 0.00% 67.78% 105.97%
Quarterly Report Q4 8-K 2022-12-31 0.00% -20.45% -38.56%
Quarterly Report Q3 8-K 2022-09-30 0.00% -63.13% -80.56%
Quarterly Report Q2 8-K 2022-06-30 0.00% -125.97% -137.96%
Quarterly Report Q1 8-K 2022-03-31 0.00% -147.15% -163.92%
Quarterly Report Q4 8-K 2021-12-31 0.00% -112.54% -113.34%
Quarterly Report Q3 8-K 2021-09-30 0.00% -106.44% -105.99%
Quarterly Report Q2 8-K 2021-06-30 0.00% -82.34% -79.51%
Quarterly Report Q1 8-K 2021-03-31 0.00% -54.33% -52.03%
Quarterly Report Q4 8-K 2020-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2020-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2020-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2020-03-31 0.00% 0.00% 0.00%